Compare Aurora Cannabis Inc (ACB) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aurora Cannabis Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Aurora Cannabis Inc trades at $3.54 (market cap $223.59M), while State Street SPDR S&P Biotech ETF trades at $158.21. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.
| ACB | XBI | |
|---|---|---|
Market Cap | $223.59M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $6.23 | $164.28 |
52-Week Low | $2.58 | $86.92 |
Enterprise Value | $168.09M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
